Treatment with the thiazolidinedione (BRL 49653) decreases insulin resistance in obese Zucker hindlimb.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

• Publication date

  1995-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2007-979932PMID 7750898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flow-induced oxygen uptake by the perfused rat hindlimb is inhibited by vasodilators and augmented by norepinephrine: a possible role for the microvasculature in hindlimb thermogenesis.

  1990cited by this paper
• Vasopressin and angiotensin II stimulate oxygen uptake in the perfused rat hindlimb.

  1988cited by this paper
• Glucose transport: locus of muscle insulin resistance in obese Zucker rats.

  1988cited by this paper
• Exercise and diet reduce muscle insulin resistance in obese Zucker rat.

  1986cited by this paper
• Physical training of Zucker rats: lack of alleviation of muscle insulin resistance.

  1983cited by this paper
• Development of pancreatic and plasma insulin in prenatal and suckling Zucker rats.

  1982cited by this paper
• Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites.

  1980cited by this paper
• Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat.

  1979cited by this paper
• Insulin and obesity

  1979cited by this paper
• Effect of experimental hyperinsulinemia on insulin binding and glucose transport in isolated rat adipocytes.

  1978cited by this paper
• Insulin response in skeletal muscle and fat cells of the genetically obese Zucker rat.

  1978cited by this paper

• Chronotherapy with a glucokinase activator profoundly improves metabolism in obese Zucker rats

  2022cites this paper
• Chronic stress and Rosiglitazone increase indices of vascular stiffness in male rats.

  2017cites this paper
• A vascular mechanism for high-sodium-induced insulin resistance in rats

  2014cites this paper
• Rosiglitazone Enhances Apolipoprotein M (Apom) Expression in Rat's Liver

  2014cites this paper
• Muscle insulin resistance resulting from impaired microvascular insulin sensitivity in Sprague Dawley rats.

  2013cites this paper
• Functional interactions between peroxisome proliferator-activated receptor-gamma and polipoprotein E isoforms in the regulation of neural functions in models of insulin resistance-relevance to Alzheimer's disease

  2012cites this paper
• Possible modulation of the antidiabetic effect of rosiglitazone by buspirone

  2012cites this paper
• Rosiglitazone Reduces Angiotensin II and Advanced Glycation End Product-dependent Sustained Nuclear Factor-κB Activation in Cultured Human Proximal Tubular Epithelial Cells

  2008cites this paper
• Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats

  2003cites this paper
• Identifying the links between obesity, insulin resistance and β‐cell function: potential role of adipocyte‐derived cytokines in the pathogenesis of type 2 diabetes

  2002cites this paper
• Normalization of skeletal muscle glycogen synthesis and glycolysis in rosiglitazone-treated Zucker fatty rats: an in vivo nuclear magnetic resonance study.

  2002cites this paper
• Thiazolidinediones

  2002cites this paper
• Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes.

  2001cites this paper
• Obesity: Pathology and Therapy

  2000cites this paper
• Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis.

  2000cites this paper
• Rosiglitazone Does Not Affect the Steady‐State Pharmacokinetics of Digoxin

  2000cites this paper
• Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats

  2000cites this paper
• The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.

  2000cites this paper
• Rosiglitazone Does Not Alter the Pharmacokinetics of Metformin

  2000cites this paper
• The clinical effectiveness and cost effectiveness of rosiglitazone for type 2 diabetes mellitus: assessment report. NICE Technology Appraisal (TA9)

  2000cites this paper
• Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve‐week, randomized, placebo‐controlled study

  1999cites this paper
• Rosiglitazone: a new therapy for Type 2 diabetes.

  1999cites this paper
• Systemic exposure to rosiglitazone is unaltered by food

  1999cites this paper
• Promising new approaches

  1999cites this paper
• Promising new approaches.

  1999cites this paper
• Amelioration by KRP-297, a new thiazolidinedione, of impaired glucose uptake in skeletal muscle from obese insulin-resistant animals.

  1999cites this paper
• Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.

  1999cites this paper
• Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

  1999cites this paper
• Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes.

  1998cites this paper
• Traitement du diabète avec du thiazolidinedione et de la sulfonylurée

  1998cites this paper
• Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC‐555

  1998cites this paper
• Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-activated Receptor (PPAR) Isoforms PPARγ2 versus PPARγ1 and Activation with Retinoid X Receptor Agonists and Antagonists*

  1997cites this paper
• Mechanisms and clinical effects of thiazolidinediones.

  1997cites this paper
• Centro de química farmacéutica tiazolidinadionas: una nueva familia de hipoglicemiantes orales

  1997cites this paper
• Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y

  1997cites this paper
• Thiazolidinediones and their effects on glucose transporters.

  1997cites this paper
• Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.

  1996cites this paper
• Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.

  1996cites this paper